Cortenema and Methotrexate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cortenema (hydrocortisone) and Methotrexate (methotrexate sodium). Common drug interactions include drug ineffective among females and colitis ulcerative among males.

The phase IV clinical study analyzes what interactions people have when they take Cortenema and Methotrexate. It is created by eHealthMe based on reports of 58 people who take the same drugs from the FDA, and is updated regularly.

What is Cortenema?

Cortenema has active ingredients of hydrocortisone. eHealthMe is studying from 735 Cortenema users. Check the latest studies of Cortenema.

What is Methotrexate?

Methotrexate has active ingredients of methotrexate sodium. It is often used in rheumatoid arthritis. eHealthMe is studying from 604,312 Methotrexate users. Check the latest studies of Methotrexate.



On Jul, 17, 2026

58 people who take Cortenema and Methotrexate together, and have interactions are studied.

Cortenema and Methotrexate drug interactions.

What are the common drug interactions of Cortenema and Methotrexate, by gender? *:

female:

  1. Drug ineffective
  2. Colitis ulcerative (inflammation of colon with ulcer)
  3. Dyspepsia (indigestion)
  4. Nausea (feeling of having an urge to vomit)
  5. Paraesthesia oral (sensation of tingling, tickling, prickling, pricking, or burning of a person's oral with no apparent long-term physical effect)
  6. Pyrexia (fever)
  7. Malaise (a feeling of general discomfort or uneasiness)
  8. Pain
  9. Procedural pain
  10. Radiculopathy (a set of conditions in which one or more nerves is affected and does not work properly)

male:

  1. Colitis ulcerative (inflammation of colon with ulcer)
  2. Headache (pain in head)
  3. Diarrhoea
  4. Discomfort
  5. Drug level decreased
  6. Fatigue (feeling of tiredness)
  7. Haematochezia (passage of stools containing blood)
  8. Malaise (a feeling of general discomfort or uneasiness)
  9. C-reactive protein increased
  10. Lethargy (tiredness)

What are the common drug interactions of Cortenema and Methotrexate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Appendicitis (inflammation of the appendix)
  2. Blood pressure decreased
  3. C-reactive protein increased
  4. Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
  5. Drug dependence
  6. Drug level below therapeutic
  7. Fatigue (feeling of tiredness)
  8. Feeling cold
  9. Headache (pain in head)
  10. Heart rate increased

20-29:

  1. Colitis ulcerative (inflammation of colon with ulcer)
  2. Drug level decreased
  3. Drug ineffective
  4. Drug level below therapeutic
  5. Intestinal resection
  6. Pneumonitis (inflammation of the walls of the alveoli in the lungs)

30-39:

  1. Colitis ulcerative (inflammation of colon with ulcer)
  2. Arthralgia (joint pain)
  3. Drug ineffective
  4. Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
  5. Fatigue (feeling of tiredness)
  6. Headache (pain in head)
  7. Nausea (feeling of having an urge to vomit)
  8. Red cell distribution width decreased
  9. Skin disorder (skin disease)
  10. Back pain

40-49:

n/a

50-59:

  1. Heart rate decreased
  2. Weight decreased

60+:

  1. Haematochezia (passage of stools containing blood)
  2. Dyspepsia (indigestion)
  3. Anaemia (lack of blood)
  4. Chronic sinusitis (long lasting inflammation of the paranasal sinuses)
  5. Colitis (inflammation of colon)
  6. Colitis ulcerative (inflammation of colon with ulcer)
  7. Constipation
  8. Drug ineffective
  9. Erythema (redness of the skin)
  10. Female genital tract fistula (passage in genital tract of female)

What are the existing conditions these people have? *

  1. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 45 people, 77.59%
  2. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 25 people, 43.10%
  3. Colitis (inflammation of colon): 13 people, 22.41%
  4. Allergies: 13 people, 22.41%
  5. Fever: 12 people, 20.69%
  6. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 10 people, 17.24%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 12.07%
  8. Urethral Disorder: 4 people, 6.90%

* Approximation only. Some reports may have incomplete information.

Do you take Cortenema and Methotrexate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cortenema and Methotrexate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cortenema:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Methotrexate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cortenema and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Methotrexate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on hydrocortisone and methotrexate sodium (the active ingredients of Cortenema and Methotrexate, respectively), and Cortenema and Methotrexate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: